Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,429 | 186 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $559.49 | 33 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $489.73 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $263.78 | 15 | $0 (2024) |
| Merck Sharp & Dohme LLC | $208.87 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $173.03 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $166.34 | 9 | $0 (2024) |
| ABBVIE INC. | $156.46 | 11 | $0 (2024) |
| Agios Pharmaceuticals, Inc. | $123.26 | 2 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $107.78 | 4 | $0 (2024) |
| PFIZER INC. | $102.87 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,572 | 82 | Novartis Pharmaceuticals Corporation ($286.24) |
| 2023 | $1,294 | 75 | Daiichi Sankyo Inc. ($315.16) |
| 2022 | $518.26 | 26 | Daiichi Sankyo Inc. ($132.01) |
| 2021 | $44.33 | 3 | Eisai Inc. ($15.27) |
All Payment Transactions
186 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Oncology | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Oncology | ||||||
| 12/16/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $83.18 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: Oncology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Oncology | ||||||
| 12/10/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $17.77 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Oncology | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Rare Disease | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $30.33 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: HEMATOLOGY | ||||||
| 10/21/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Genetically Defined Disease | ||||||
| 10/17/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 22 | 94 | $18,410 | $5,558 |
| 2022 | 2 | 53 | 171 | $36,945 | $11,624 |
| 2021 | 4 | 75 | 228 | $44,992 | $15,835 |
| 2020 | 3 | 145 | 246 | $37,755 | $9,861 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 22 | 94 | $18,410 | $5,558 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 26 | 79 | $15,405 | $4,798 | 31.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 45 | $12,375 | $4,210 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 47 | $9,165 | $2,616 | 28.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 27 | 115 | $22,425 | $7,460 | 33.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 11 | 41 | $11,275 | $4,136 | 36.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 34 | $6,630 | $2,302 | 34.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 17 | $2,142 | $1,157 | 54.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 13 | 21 | $2,520 | $780.47 | 31.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 59 | 117 | $22,815 | $5,950 | 26.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 62 | 93 | $11,160 | $2,797 | 25.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 24 | $2,880 | $835.26 | 29.0% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Facility | 2020 | 12 | 12 | $900.00 | $279.12 | 31.0% |
About Robert Duncan, P.A
Robert Duncan, P.A is a Physician Assistant healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669492609.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Duncan, P.A has received a total of $3,429 in payments from pharmaceutical and medical device companies, with $1,572 received in 2024. These payments were reported across 186 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($3,429).
As a Medicare-enrolled provider, Duncan has provided services to 295 Medicare beneficiaries, totaling 739 services with total Medicare billing of $42,878. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Shreveport, LA
- Active Since 07/20/2006
- Last Updated 06/19/2008
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1669492609
Products in Payments
- INJECTAFER (Drug) $266.67
- Enhertu (Drug) $225.91
- KEYTRUDA (Biological) $208.87
- Fabhalta (Drug) $170.43
- IMBRUVICA (Drug) $168.47
- EPKINLY (Drug) $160.21
- DARZALEX (Biological) $157.64
- OPDIVO (Biological) $150.75
- PROMACTA (Drug) $124.86
- PYRUKYND (Drug) $123.26
- Rezlidhia (Drug) $107.78
- OXBRYTA (Drug) $107.41
- CALQUENCE (Drug) $100.18
- Lenvima (Drug) $96.43
- LIBTAYO (Biological) $92.03
- DAXXIFY (Drug) $83.18
- ULTOMIRIS (Biological) $79.99
- KISQALI (Drug) $68.90
- ENHERTU (Drug) $66.91
- SCEMBLIX (Drug) $57.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Shreveport
Emily Bergeron, Pa-C, PA-C
Physician Assistant — Payments: $13,730
Seth Miller, Pa-C, PA-C
Physician Assistant — Payments: $12,090
Cassie Miller, Pa, PA
Physician Assistant — Payments: $11,503
Cedric Willis, Pa-C, PA-C
Physician Assistant — Payments: $9,867
Megan Johnson
Physician Assistant — Payments: $8,912
Dustin Hadley, Pa-C, PA-C
Physician Assistant — Payments: $8,693